Pharmaceutical

STAT+: Senate Republicans throw cold water on so-called...

House Republicans want to use a small cut to hospitals’ Medicare payments to hel...

Opinion: PEPFAR has been a lifeline in Ukraine. Now it’...

PEPFAR has been a lifeline in Ukraine. Now, two people who work for SAFEMed in U...

STAT+: U.S. Supreme Court to review controversial Purdu...

After weeks of anticipation, the U.S. Supreme Court on Monday will hear argument...

STAT+: Patients want test results now, and radiologists...

Some radiologists worry that patients will end up more anxious than they were be...

People with congenital heart disease are living longer ...

“Adult congenital patients are not an emerging heart failure subgroup, but one t...

STAT+: Texas AG accuses Pfizer of ‘intentionally’ overs...

The Texas attorney general has filed a lawsuit accusing Pfizer of “unlawfully” a...

CDC Director Mandy Cohen unscathed in her first congres...

House Republicans struggled to pin the new CDC director down on what they see as...

AbbVie’s big deal, CAR-T’s risks, & getting a biotech job

This week on the "The Readout LOUD" podcast: Are ADCs having a moment? Is CAR-T ...

STAT+: Radiology captures the tension between AI’s pote...

This year’s meeting of the Radiological Society of North America surfaced the te...

Takeda, Janssen join wearable maker to measure scratchi...

In the latest edition of Health Tech newsletter: Takeda, Janssen team up with Ac...

Do GLP-1s have a future treating alcoholism?

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of ta...

AbbVie will pay $10 billion for Immunogen, acquiring an approved treatment for o...

STAT+: AbbVie buys Immunogen, maker of targeted cancer ...

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said, ac...

Opinion: Diagnostic tests for rare conditions present a...

Diagnostic tests for rare conditions present a mathematical conundrum.

Bacterial Conjunctivitis drugs in development, 2023

The Bacterial Conjunctivitis drugs in development market research report provide...

Gliosarcoma drugs in development, 2023

The Gliosarcoma drugs in development market research report provides comprehensi...